205371-26-2 Usage
General Description
2-Bromo-5-(trifluoromethoxy)phenol is a chemical compound with the molecular formula C7H4BrF3O2. It is a phenolic compound with a bromine atom and a trifluoromethoxy group attached to a benzene ring. This chemical is primarily used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. It has also been used as a building block in the development of organic compounds for various chemical and industrial applications. Additionally, 2-Bromo-5-(trifluoromethoxy)phenol has been studied for its potential biological activities and has shown promising results in antimicrobial and antifungal activities. However, it is important to handle this chemical with caution as it may pose health and environmental risks.
Check Digit Verification of cas no
The CAS Registry Mumber 205371-26-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,5,3,7 and 1 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 205371-26:
(8*2)+(7*0)+(6*5)+(5*3)+(4*7)+(3*1)+(2*2)+(1*6)=102
102 % 10 = 2
So 205371-26-2 is a valid CAS Registry Number.
InChI:InChI=1/C7H4BrF3O2/c8-5-2-1-4(3-6(5)12)13-7(9,10)11/h1-3,12H
205371-26-2Relevant articles and documents
DERIVATIVES OF 6-SUBSTITUTED TRIAZOLOPYRIDAZINES AS REV-ERB AGONISTS
-
Page/Page column 52-53; 75, (2013/04/13)
The present invention provides novel 6-substituted [1,2,4]triazolo[4,3-b]pyridazines that are agonists of Rev-Erb. These compounds, and pharmaceutical compositions comprising the same, are suitable means for treating any disease wherein the activation of Rev-Erb has therapeutic effects, for instance in inflammatory and circadian rhythm-related disorders or cardiometabolic diseases.
HETEROARYL FUSED PYRIDINES, PYRAZINES AND PYRIMIDINES AS CRF1 RECEPTOR LIGANDS
-
Page/Page column 57, (2010/02/11)
Substituted heteroaryl fused pyridine, pyrazine, and pyrimidine compounds that act as selective modulators of CRF 1 receptors are provided. These compounds are useful in the treatment of a number of CNS and periphereal disorders, particularly stress, anxi
